Research Interest: It is Mainly Lies in Two Areas. First I Focused on Applying Statistical Methods and Multilevel Modeling in Randomized Clinical Trials and Family-Based Health-Related Interventions, Particularly in Substance Abuse, HIV/AIDS, STD, Sexual Risk Behaviors and Minority Health Disparities. Second, I am Interested in Epidemiology Studies 0f Chronic Disease Including Alcohol Use Disorder, Drug Abuse, Obesity, Diabetes, Metabolic Syndrome, Hypertension, Cardiovascular Disease and Stroke; and Also from Genetic Epidemiology Point of View to Examine Complex Disease Including Alcohol Dependence and Co-Morbidity, and Alzheimer Disease Etc. 

Research Interest: He Also Conducted Basic Research in Regard to the Investigation of the Role of Immunological Aspects in Kidney Diseases Including Nephritic Syndrome and Diabetic Nephropathy.

Research Interest: A Biomedical Researcher with a Focus on Neurobehavioral, Metabolic and Endocrine Disorders.

Research Interest: Nutrition, Obesity, Weight, Diet

Research Interest: Internal Medicine and Cardiology

China Diabetes Impact Study is funded by IDF and technically supported by Division of Diabetes Translation of CDC. It is a follow-up study of China National Diabetes and Metabolic Disorder Study. A total of 12 study sites participated in the China Diabetes Impact Study. I am the national program coordinator and the investigator of Beijing study site. All study participants with DM, NDM and IGR were interviewed and collected information about their health care service use, medical expenditure, etc. 

Research Interest: Directed Toward the Idenfication of Bioactive Compound, the Total Synthesis, and Structural Modification of Natural Products from Chinese Herds, Drug Design and Synthesis Based on Natural Lead Compounds, Mechanism Study of Natural Products, Peptide Investigation Initiated from Natural Resources, the Interface of Organic Chemistry and Cell Biology.

Research Interest: Nutrition, Weight management, Obesity Evaluation, Behavior Change Interventions, Critical Thinking, Health Disparity, Curriculum and Program Development, Type 2 Diabetes

Research Interest: Cardiovascular Disease, Electrophysiology, Pacemaker, ICD and CRT Therapy, Metabolic Syndrome, Bidirectional Effect of CVD and CKD

Research Interest: Integrated Pharmaco-Physiology, Brain-Gut Interactions, Stress-Related Functional Gastrointestinal Diseases, Ingestive Behavior-Associated Gastrointestinal Neuroendocrinology, and Bariatric Surgery

Lawrence Lavery is a Professor in the Department of Plastic Surgery, as well as Director of Clinical Research in the Department of Plastic Surgery, at the University of Texas Southwestern Medical Center, Dallas, TX.  His research group has published 210 peer reviewed papers and has received extramural funding from the Veterans Administration, the National Institute of Health, the Agency for Healthcare Research and Quality, the American Diabetes Association, and the American College of Foot and Ankle Surgeons. 

Research Interest: Diabetes, Ulcers, Infections, Neuropathy and Osteomyelities

Grants: Supporting with number of grants

List of Publications:
1.    Lavery LA, Oz OK, Bhavan K, Wukich DK.  Diabetic Foot Syndrom in the Twenty-First Century.  Clin Podiatr Med Surg. 2019 July; 3, 355-359.
2.    Kim, PJ, Attinger CE, Orgill D, Galiano RD, Steinberg JS, Evans KK, Lavery LA.  Complex Lower Extremity Wound in the Complex Host:  Results from a Multicenter Registry.  Plastic and Reconstructive Surgery-Global. 2019 Apr.  Epub ahead of print.
3.    Ahn J, Raspovic KM, Liu GT, Lavery LA, La Fontaine J, Nakonezny PA, Wukich, DK.  Lower Extremity Necrotizing Fasciitis in Diabetic and Nondiabetic Patients:  Mortality and Amputation.  Int J Low Extrem Wounds.  2019 Apr.  Epub ahead of print.  PMID: 30929530.
4.    Lavery LA, Bhavan K, Wukich DK.  Biofilm and diabetic foot ulcer healing:  all hat and no cattle.  Annals of Translational Medicine 2019 Mar.  Epub ahead of print.
5.    La Fontaine J, Crisologo PA, Lavery L.  Current concepts in curative surgery for diabetic forefoot ulcers.  The Foot 2019 Jan 10 (39) 37-44.  Epub ahead of print.
6.    Olson E, Mahar KM, Morgan L, Fillmore C, Holland C, Lavery L.  Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and Patients with Diabetic Foot Ulcers.  Clin Pharmacol Drug Dev. 2019 Feb 5. Epub ahead of print.  PMID:  30720931.
7.    Liu JW, Ahn J, Raspovic KM, Liu GT, Nakonezny PA, Lavery LA, Wukich DK.  Increased Rates of Readmission, Reoperation, and Mortality Following Open Reduction and Internal Fixation of Ankle Fractures are Associated with Diabetes Mellitus. J Foot Ankle Surg. 2019 Feb 11. Epub ahead of print.
8.    Ryan EC, Ahn J, Wukich DK, Kim PJ, La Fontaine J, Lavery LA.  Diagnostic Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein in Osteomyelitis of the Foot in Persons without Diabetes.  J Foot Ankle Surg. 2019 Jan 23.  Epub ahead of print.
9.    Ahn J, Raspovic KM, Liu GT, Lavery LA, La Fontaine J, Nakonezny PA, Wukich DK.  Rental Function as a Predictor of Early Transmetatarsal Amputation Failure.  Foot Ankle Spec. 2018 Dec 12.  Epub ahead of print.  PMID:  30537872.
10.    Lavery LA, Crisologo PA.  Non-invasive vascular screening test to diagnose peripheral vascular disease.  Ann Transl Med. 2018 Dec; 6(Suppl 2).  PMID:  30740429.
11.    Yavuz M, Ersen A, Hartos J, LAVERY LA, Wukich D, Hirschman G, Armstrong D, Quiben M, Adams L.  Temperature as a Causative factor in Diabetic Foot Ulceration:  A Call to Revisit Ulcer Pathomechanics.  J Am Podiatr Med Assoc. 2018 Nov 14. (Epub ahead of print).  PMID:  30427732.
12.    Niederauer MQ, Michalek JE, Liu Q, Papas KK, LAVERY LA, Armstrong DG.  Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control:  a randomized, double-blind, multicenter study.  J Wound Care.  2018 Sep 1;27(Sup9): S30-S45. PMID: 30207844.
13.    LAVERY, LA, Fulmer J, Shebetka KAS, Regulski M, Vayer, D, Fried D, Kashefsky H, Owings TM, Nadarajah J, Phelan DHK.  Open-label Extension Phase of a Chronic Diabetic Foot Ulcer Multicenter, Controlled, Ramdomised Clinical Trial Using Cryopreserved Placental Membrance.  Wounds Epub 2018 June.  PMID:  30256747.
14.    Raspovic KM, Wukich DK, Naiman DQ, LAVERY LA, Kirsner RS, Kim PJ, Steinberg JS, Attinger CE, Danilkovitch A.  Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting.  Wound Repair Regen, 2018 Mar; 26(2): 213-220.  PMID:  29683538.
15.    Ahn J, Del Core MA, Wukich DK, Liu GT, Lalli T, VanPelt MD, La Fontaine J, Lavery LA, Raspovic KM.  Scoring mental health quality of life with the SF-36 in patients with and without diabetes foot complications.  Int J Low Extrem Wounds.  2018 Mar.  PMID:  29546783.
16.    LAVERY LA, Lavery DC, Hunt NA, La Fontaine J, Lavery RD.  Does the start of dialysis initiate a period of increased risk of ulceration or amputation?  J Am Podiatr Med Assoc.  2018 Jan; 108-(1):1-5.  PMID:  29547031.
17.    Van Asten SAV, Mithani M, Peters EIG, La Fontaine J, Kim PJ, Lavery LA.  Complications during the treatment of diabetic foot osteomyelitis.  Diabetes Res Clin Pract. 2018 Jan;135:58-64. PMID: 28951333. 
18.    Crisologo PA, Lavery LA.  Remote home monitoring to identify and prevent diabetic foot ulceration.  Ann Transi Med.  2017 Nov;5(21):430.  PMID:  29201882.
19.    Lavery LA, Ryan EC.  Does Continuous Diffusion of Oxygen Improve Diabetic Foot Ulcer Healing?  J Diabetes Sci Technol. 2017 Sep; 11(5):892-893.  PMID: 28728437.
20.    Sanniec K, Nguyen T, van Asten S, La Fontaine J, Lavery LA.  Split-Thickness Skin Grafts to the Foot and Ankle of Diabetic Patients.  J Am Podiatr Med Assoc.  2017 Sep; 107(5):365-368.  PMID:  29077498.

Research Interest: My Research Interests Span Many Areas Including Bioinformatics and Metabolomics. As a Phd Student at Center of Magnetic Resonance of University of Florence (Italy), My Research Focused on the Metabolomic Analysis of Biofluid (E.G., Urine, Serum, Saliva) and Tissue (E.G., Intact Human Liver) Samples. I Used Nuclear Magnetic Resonance (NMR) Spectroscopy and Advanced Statistical Analysis Techniques to Identify and Predict Metabolomic Fingerprints. In Particular, I Used NMR-Based Metabolomic Analysis to Identify a Fingerprint of Poor-Survival in the Serum of Patient with Metastatic Colorectal Cancer.
Now as Postdoc at Dana-Farber Cancer Institute, My Current Research Focuses on Identifying Metabolic Fingerprint Predictors of Prostate Cancer Development and Progression to Improve our Understanding of The Mechanisms Linking Metabolism with the Biology of Prostate Cancer. Moreover, I Will Contribute on Developing of New Standard Operation Procedures for Metabolomic Analysis in Formalin Fixed Paraffin Embedded Tissues. 

Research Interest: Epidemiology, pathogenesis, diagnosis and treatment of fatty liver (metabolic and viral); genetic determinants of fatty liver; metabolic syndrome; insulin resistance; association between fatty liver, metabolic syndrome, diabetes and cardiovascular diseases;  liver ultrasonography.

Research Interest: Own Publications in Different Areas of Health, among them Obesity and Metabolic Syndrome which is a Major Focus of Interest, Pricipalmente when Combined with Physical Exercises. 

Research Interest: Immunology such as Autoimmune Diabetes (Type 1).